Long non-coding RNA linc00645 promotes TGF-β-induced epithelial–mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma

Author:

Li Chenlong,Zheng Hongshan,Hou Weiliang,Bao Hongbo,Xiong Jinsheng,Che Wanli,Gu Yifei,Sun Haiming,Liang Peng

Abstract

Abstract Accumulating evidence indicates long noncoding RNAs (lncRNA) play a vital role in tumor progression. However, the role of linc00645-induced accelerated malignant behavior in glioblastoma (GBM) remains unknown. In the present study, linc00645 expression was significantly upregulated in GBM tissues and cell lines. High level of linc00645 was associated with poor overall survival in GBM patients. Knockdown of linc00645 suppressed the proliferation, stemness, migration, invasion, and reversed transforming growth factor (TGF)-β-induced motility of glioma cell lines. Furthermore, linc00645 directly interacted with miR-205-3p and upregulated of miR-205-3p impeded efficiently the increase of ZEB1 induced by linc00645 overexpression. Moreover, knockdown of linc00645 significantly suppressed the progression of glioma cells in vivo. miR-205-3p was a target of linc00645 and linc00645 modulates TGF-β-induced glioma cell migration and invasion via miR-205-3p. Taken together, our findings identified the linc00645/miR-205-3p/ZEB1 signaling axis as a key player in EMT of glioma cells triggered by TGF-β. These data elucidated that linc00645 plays an oncogenic role in glioma and it may serve as a prognostic biomarker and a potential therapeutic target for the treatment of glioma in humans.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Reference56 articles.

1. Khasraw, M., Ameratunga, M. S., Grant, R., Wheeler, H. & Pavlakis, N. Antiangiogenic therapy for high-grade glioma. Cochrane Database Syst. Rev. 9, CD008218 (2014).

2. Wang, J., Su, H. K., Zhao, H. F., Chen, Z. P. & To, S. S. Progress in the application of molecular biomarkers in gliomas. Biochem. Biophys. Res. Commun. 1, 1–4 (2015).

3. Bastien, J. I., Mcneill, K. A. & Fine, H. A. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. Cancer 4, 502–516 (2015).

4. Ombrato, L. & Malanchi, I. The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit. Rev. Oncog. 5, 349–361 (2014).

5. Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat. 1, 8–20 (1995).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3